ArticleBMC cancer2013

Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer.

Michele T Yip-Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.